SKYRIZI (risankizumab-rzaa) injection
SKYRIZI is a prescription medicine used for the treatment of plaque psoriasis, psoriatic arthritis and Crohn’s disease. Brand Name: SKYRIZI (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2019. FDA approved risankizumab-rzaa (brand name SKYRIZI) is not (yet) registered or available in India but on request Indian patient can buy SKYRIZI at the lowest price.
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
SKYRIZI (risankizumab-rzaa) injection
SKYRIZI is an interleukin-23 antagonist indicated for the treatment of:
• moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
• active psoriatic arthritis in adults.
• moderately to severely active Crohn’s disease in adults.
Risankizumab, sold under the brand name Skyrizi, is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, and Crohn’s disease. It is designed to target interleukin 23A (IL-23A). It is given by subcutaneous injection. Risankizumab is approved for medical use in the European Union, the United States, Canada, and Japan
Drug (Brand / Generic): SKYRIZI / risankizumab-rzaa
Current Indications: plaque psoriasis, psoriatic arthritis and Crohn’s disease
Marketed by:: AbbVie Inc.
Approval Date: 2019
Dosage forms and strengths of SKYRIZI (risankizumab-rzaa) injection
Subcutaneous injection
• Injection: 150 mg/mL in each single-dose prefilled pen.
• Injection: 75 mg/0.83 mL in each single-dose prefilled syringe.
• Injection: 90 mg/mL in each single-dose prefilled syringe.
• Injection: 150 mg/mL in each single-dose prefilled syringe.
• Injection: 180 mg/1.2 mL (150 mg/mL) in each single-dose prefilled
cartridge.
• Injection: 360 mg/2.4 mL (150 mg/mL) in each single-dose prefilled
cartridge.
Intravenous infusion
• Injection: 600 mg/10 mL (60 mg/mL) in each single-dose vial.
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ SKYRIZI (risankizumab-rzaa) injection ”. FDA approved risankizumab-rzaa (brand name SKYRIZI) is not (yet) registered or available in India but on request Indian patient can buy SKYRIZI at the lowest price. Confirmation of the order for SKYRIZI (risankizumab-rzaa) injection will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to FDA approved risankizumab-rzaa (brand name SKYRIZI) India.
For personal use, get access to FDA approved risankizumab-rzaa (brand name SKYRIZI) India. On request, We have imported and delivered Anti-cancer medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
SKYRIZI Sourcing & Delivery
Alleviare India specializes in sourcing and supplying SKYRIZI, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of SKYRIZI in India.
How much does SKYRIZI cost in the India?
Kindly reach out to us for SKYRIZI (risankizumab-rzaa) injection price and availability confirmation.
The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import SKYRIZI to India?
To import risankizumab-rzaa SKYRIZI, patients or government hospitals can place an order on behalf of the patients.
The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is SKYRIZI available in India?
SKYRIZI risankizumab-rzaa is a prescription medication, which means it legally requires a medical prescription to be dispensed. Alleviare India assists in importing cancer medicines through the named patient supply (NPS) program. They provide information on the availability and prices of medications in various cities in India, such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune. Alleviare ensures 100% transparency and helps find genuine and reliable sources from Canada, Europe, USA, and Australia. They can facilitate the supply of SKYRIZI (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements.
Please contact or mail @ – info@alleviareindia.com +91 9289711087 / 9289711088 for SKYRIZI availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is risankizumab-rzaa available in India?
Yes, FDA approved risankizumab-rzaa (brand name SKYRIZI) is not (yet) registered or available in India but on request Indian patient can buy SKYRIZI at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand SKYRIZI (risankizumab-rzaa) injection . The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to SKYRIZI (risankizumab-rzaa) injection , they can inquire and find further information by sending their inquiries to ALS.
